Decitabine+BUCY vs BUCY Conditioning Regimen for MLL+ Acute Leukemia Undergoing Allo-HSCT

Clinical trial NCT03596892 · UNKNOWN

Trial details

NCT number: NCT03596892
Sponsor: Nanfang Hospital, Southern Medical University
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Allogeneic Hematopoietic Stem Cell Transplantation Conditions Mixed-lineage-leukemia (MLL)-Rearranged Acute Leukemia

Start date: 2018-07-01
Primary completion: 2021-06-01
Enrollment: 122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.